Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 816-324-8 | CAS number: 2044770-20-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Study Initiation date: October 17, 2019 - Experimental Completation Date December 13, 2019
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 020
- Report date:
- 2020
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- Ministry of Environmental Protection of the People´s Repiblic of China: The Guidelines for Testing of Chemicals (HJ/T 153-2004) Appendix 406 Skin Sensitisation Test.
Ministry of Environmental Protection chemical registration center. The Guidelines for the Testing of Chemicals-Health Effects [M]. Appendix 406 Skin Sensitisation Test. The second edition. Beijing: China Environment press: 2013: 40-46.
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- Buehler test
- Justification for non-LLNA method:
- The study was performed within the aim of registration of the product for other regulatory program outside Europe.
Test material
- Reference substance name:
- 1,1'-[(3-{bis[3-(dimethylamino)propyl]amino}propyl)imino]dipropan-2-ol
- EC Number:
- 816-324-8
- Cas Number:
- 2044770-20-7
- Molecular formula:
- C19H44N4O2
- IUPAC Name:
- 1,1'-[(3-{bis[3-(dimethylamino)propyl]amino}propyl)imino]dipropan-2-ol
- Test material form:
- liquid
- Details on test material:
- Storage conditions: room temperature
Constituent 1
- Specific details on test material used for the study:
- Test Item code: 2019C142
Product name: DABCO® NE 1550
Chemical name: 1,3-propanediamine, N1-(3-aminopropyl)-N1-[3-dimethylamino)propyl]-
N3,N3-dimethyl-, reaction products with propylene oxide
Molecular formula: C19H42N4O2
CAS number: 2044770-20-7 (new) 1900709-98-9 (old)
EC number: 816-324-8
Batch/Lot number: UR18201873
Purity: 100 %
Storage Conditions: Store at room temperature (10 – 30 °C)
Protective measures: According to the material safety data sheet provided by the client, uniform, masks, caps, gloves and glasses were used to ensure the health and safety of the personnel
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Hartley
- Sex:
- male
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Liaoning Changsheng Biology Technology Co., Ltd
- Females (if applicable) nulliparous and non-pregnant: only male animals were used
- Microbiological status of animals, when known:
- Age at study initiation: 5 weeks (grouping)
- Weight at study initiation: 319.86- 380.14 g (grouping)
- Housing: The 2-6 guinea pigs were fed in a plastic cage (L 92 cm x W 62 cm x H 25 cm), and the housing condition followed the national standard (GB 14925-2010).
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 7 days
- Indication of any skin lesions: none
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20.01-24.00 °C
- Humidity (%):40.00-69.40%
- Air changes (per hr): not reported
- Photoperiod (hrs dark / hrs light): 12 h dark / 12 h light
- IN-LIFE DATES: From: October 17, 2019 To: December 13, 2019
Study design: in vivo (non-LLNA)
Induction
- Route:
- epicutaneous, occlusive
- Vehicle:
- unchanged (no vehicle)
- Concentration / amount:
- undiluted (100%)
- Day(s)/duration:
- 21 days (three weeks treament). Inductiojn Exposure ( day 0, day 7 and day 14)
- Adequacy of induction:
- highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically
Challenge
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- 25%
- Day(s)/duration:
- On day 28 for 6 hours. Observation were carried out at 1, 24 and 48 hours
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- Pre-Study: 2 animals were used randomly
Main Study: 20 animals in the treated group, 10 animals in the control group - Details on study design:
- RANGE FINDING TESTS:
Pre-study
Animals: 2
Dosing Method: 0.2 mL undiluted (left flank first animal); 0.2 mL 50% of the test item solution(right flank of the first animal; 0.2 mL 25% of the test item solution (left flank of the second animal); 0.2 mL 12.5% of the test item solution (right flank on the second animal).
For every treatment the test patch systems were held in contact with skin by an occlusive patch and glutting by medical adhesive plaster.
The test patch systems were removed after 6 hours. Degreasing cotton was used for scrubbing the test area after removing the patch with ultrapure water.
Observation: The skin reaction was observed after removing the patch on 1st hour and 24th hour of treatment.
Dose design: The dose of the test item used for each induction exposure would cause highest irritation of mild irritation, and the dose used for the challenge exposure would be the highest non-irritation dose, according to the result of the pre-study. If all doses used in pre-study would not irritate skin, the highest dose would be used in induction and challenge.
Results: 0.2 mL test item was used in induction and 0.2 mL 25% was used in challenge
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 3
- Exposure period: 6 h
- Test groups: Undiluted test sample was applied on the left flank cleared of air
- Control group: the same operation with the treated group was completed except test item
- Site: left flank
- Frequency of applications: 7 d interval (treatment on day 0, 7 and 14)
- Duration: 14 d
- Concentrations: undiluted
Degreasing cotton was used for scrubbing the test area after removing the patch with corn oil.
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: day 28, 14 d after final induction
- Exposure period: 6 h
- Test groups: 25% (w/v in water)
- Control group: 25% (w/v in water)
- Site: right flank
- Concentrations: 25% (w/v in water)
- Evaluation (h after challenge): 24 h and 48 h
Degreasing cotton was used for scrubbing the test area after removing the patch with corn oil.
Re-challenge was not carried out. - Positive control substance(s):
- yes
- Remarks:
- The procedure for skin sensitisation study in guinea pigs used was validated, 2-mercaptobenzothiazole, as positive control test item. The test was started in May 24, 2019 and finished on June 27, 2019.
Results and discussion
- Positive control results:
- The sensitisation incidence of 2-mercaptobenzothiazole was 30%. Thus, the experimental method and the animals used in this study were considered to be sentitive and reliable.
In vivo (non-LLNA)
Resultsopen allclose all
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 25%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No clinical observation
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 25%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No clinical observation
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 25%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- No abnormal findings in the treated guinea pigs in test
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 25%
- No. with + reactions:
- 1
- Total no. in group:
- 20
- Clinical observations:
- There was noabnormal general findings in the control and treated guinea pigs in test
- Remarks on result:
- other: one animal of the treated group was found discrete erythema on the test area, and the other 19 animals of the treated gropp were no visible changes
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The sensitisation incidence of the control group is 0% and the sensitisation incidence of the treated group is 5%. Thus, under the GHS classification criteria DABCO NE 1550 is not classified as skin sensitiser.
- Executive summary:
The skin sensitization potential of DABCO NE 1550 was determined in guinea pigs following repeated dermal application in an OECD TG 406 study (Buehler Method) under GLP condition.
0.2 mL undiluted test item was used in induction, and 0.2 mL 25% test item was used in challenge.
0.2 mL was applied to the shaved left flank every treated animal (20 animals) once per week during the induction period of three consecutive weeks. The control guinea pigs (10 animals) were handled in the same manner, but without test item in the induction. About two weeks after the third exposure, 0.2 mL 25% test item solution was applied to the shaved right flank of the treated and the control guinea pigs in challenge.
Results: Following each induction, there were no visible changes of the control animals, all animals of the treated group were found slight erythema of test area.
After challenge, there was not visible changes of the control animals, while one animal of the treated group was found discrete erythema on test area, and other 19 animals of the treated group were no visible changes. The sensitization incidence is 5%.
Thus, under the GHS classification criteria DABCO NE 1550 is not classified as skin sensitiser.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.